Anyone wish to discuss Quarterly Revenue projections that are possible given mandate, existing business segments already experiencing growth at APDN, and new opportunities in pharma, consumer, and other defense related due to come.
Wanting to be conservative here, and for simplicity 1st qrtr projections will begin Jan-March 2013:
With assumption that we begin seeing quarterly rev numbers moving in this direction, and news releases indicative of major contracts,etc--do you believe the market will begin valuing this company in the $1.00-$2.00 range in 2013.
Assumption also is that 20-25 of the 100+ defense related companies will give APDN the majority of the work.
Also, what premium over and above the projected valuation can be attached to the idea that APDN will become increasingly a very "talked-about" company. A real story stock?
As far as a buyout (there has been absolutely NO talk of that yet, but since it was mentioned), with a market of $300 billion annually (however they came up with that) if DNA marking cost was 1% that would be revenue of $3 billion annually (almost unfathomable). $3b / 650m shares = closing in on $5 a share.
That would be a 30 bagger from $.15. Hows that for optimistic boys and girls.
And that still only gives the insiders around $800,000,000 to split up amungst themselves because of all the shares they have issued, probably not enough.
Why are you assuming only 20-25 of 100 companies give work to APDN. All 100 companies should go thru APDN. In that first quarter of 2013 will get revenues more than $6 million . That's my conservative estimate.